What Is Xylazine and Why Is It in Philly's Drug Supply?
Xylazine is a veterinary sedative — it is not approved for human use. Drug traffickers began mixing it with fentanyl because it extends the duration of the drug's effects, helps suppress withdrawal, and increases the weight and profitability of the product. Philadelphia was the first major U.S. city where xylazine became pervasive, and it remains one of the cities most affected. Xylazine is not an opioid — naloxone does not reverse a xylazine overdose. It does not block opioid receptors. In a combined fentanyl-xylazine overdose, naloxone may partially reverse the fentanyl component, but the person may remain sedated due to xylazine.
What Are Xylazine Wounds?
One of the most distinctive harms from xylazine is the severe, slow-healing skin ulcerations it causes — often called 'tranq wounds.' These wounds can appear anywhere on the body (not just injection sites) and can progress rapidly if untreated, in some cases requiring amputation. Many people entering Philadelphia inpatient treatment programs have active xylazine wounds that require coordinated wound care alongside addiction treatment. Choosing a program with experience managing tranq wounds is important for Philadelphia patients.
What Is Medetomidine — And Has It Replaced Xylazine?
As of 2025, medetomidine has largely replaced xylazine in Philadelphia's drug supply. It was detected in 87% of drug samples tested as of January 2025. Like xylazine, it is an alpha-2 adrenergic agonist — but it is 200 times more potent. Medetomidine withdrawal causes a more severe syndrome than xylazine: intractable vomiting, tremors, rapid heart rate, and sweating. In some cases, withdrawal requires admission to an intensive care unit. This is why attempting home detox from Philadelphia street drugs in 2026 is so dangerous — the withdrawal from adulterants alone can be medically serious.
What Does Xylazine / Medetomidine Detox Involve?
Because xylazine and medetomidine are not opioids, opioid withdrawal protocols alone are insufficient. Clinical teams managing these patients typically use a combination of alpha-2 agonists (like clonidine) and comfort medications to manage the specific withdrawal syndrome, alongside opioid withdrawal management for the fentanyl component. Wound care is integrated into the treatment plan for patients with xylazine injuries. This specialized protocol requires clinical experience — it's one reason Philadelphia-specific placement expertise matters.
Ready to Talk? Call (215) 792-4574 — Available 24/7.
Free insurance verification in minutes. Most PPO plans cover inpatient rehab. Confidential, no obligation.